Mlp Saglik Hizmetleri As Class B · BIST:MPARK
Mlp Saglik Hizmetleri As Class B — MLP Care — H1 2025 Earnings Presentation
18 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, Jul 28, 2025
Slide 1: MLPCARE H1 2025 Presentation
MLPCARE H1 2025 PRESENTATION J u l y 2 8 th, 2 0 2 5
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava
Slide 3: Muharrem Usta, Chairman & CEO
MUHARREM USTA CHAIRMAN & CEO
Slide 4: Q2 2025 Financials at a Glance
Q2 2025 Financials at a Glance • Strong growth in top line Revenue EBITDA TL 11,871 m TL 2,897 m • Revenue growth supported by domestic 14% Up 13% Up H1 2025: H1 2025: private medical insurance 10% Growth 9% Growth • EBITDA margin remained flat despite the addition of new hospitals to the group last
Slide 5: Expanding its Footprint in Türkiye and Abroad
Expanding its Footprint in Türkiye and Abroad 2024 New Hospitals Bed Capacity Square Meters Consolidation Capacity Starting From +6.300 Bed MP İncek - Ankara 182 8.225 May, 2024 MP İzmir 143 12.500 June, 2024 10% MP Gebze - Kocaeli 100 18.000 July, 2024 MP Ataşehir – İstanbul 80 8.000 July, 2024 MP
Slide 6: Burcu Öztürk, CFO
Slide 7: Revenue Is up by 10%
Revenue Is up by 10% Revenue (TLm) 10.3% 24,331 22,054 14.1% 11,871 10,400 Q2 2024 Q2 2025 H1 2024 H1 2025 Denotes growth of Revenue vs. the same period of the last year 7
Slide 8: Continued Improvement in Average Prices
Continued Improvement in Average Prices Outpatient Revenues (TLm) Inpatient Revenues (TLm) 20.2% 10.8% 14.2% 6.0% 6.1% 4.9% 536 1,247 604 8,807 10,590 494 11,242 10.638 10,144 10.144 H1 2024 Volume & Mix Price H1 2025 H1 2024 Volume & Mix Price H1 2025 Average Revenue Per Visit (ARPV) Average Revenu
Slide 9: EBITDA is up by 13%
EBITDA is up by 13% EBITDA (TLm)1 8.6% 6,107 5,539 13.1% 2,897 2,562 Q2 2024 Q2 2025 H1 2024 H1 2025 1 EBITDA and EBITDA margin calculated by deducting general administrative expenses from gross profit and adding depreciation and amortization expenses Denotes growth of EBITDA vs. the same period of
Slide 10: Prudent Cost Management
Prudent Cost Management Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 25.1% 24.7% Material costs as a % of revenue decreased by 171bps due to effective inventory management 9.3% 10.6% Doctor costs as a % of
Slide 11: Bottom Line Improves Excluding One-off
Bottom Line Improves Excluding One-off Net Profit (TLm) Net Profit (TLm) Excluding One-off Equity Holders of the Parent 25.2% (5.6%) 2.419 2.284 2.284 1.824 26.7% (26.4%) 1.419 1.044 1.045 824 Q2 2024 Q2 2025 H1 2024 H1 2025 Q2 2024 Q2 2025 H1 2024 H1 2025 Denotes growth/decrease of Net Profit and N
Slide 12: Debt Structure: Leverage Ratio Improves
Debt Structure Leverage Ratio Improves Net Debt Net Debt excl. IFRS 16 8,798 2,705 6,139 0.7x 833 0.2x 0.5x 0.1x 2024 H1 2025 2024 H1 2025 *All figures are presented in million Turkish Lira 12 Denotes Net Debt / EBITDA multiples
Slide 13: Cash Flow
Cash Flow million TL H1 2025 H1 2024 Change EBITDA 6,017 5,539 478 Operating Cash Flow decreased due to increased working capital requirements Changes in working capital (911) (510) (401) Tax paid (689) (530) (159) CAPEX increased due to renovation in existing hospitals and new hospital Other (1
Slide 14: Q&A
Q&A
Slide 15: Closing Remarks
Closing Remarks MUHARREM USTA CHAIRMAN & CEO
Slide 16: Historical Balance Sheet
Historical Balance Sheet Reviewed Audited TLm June 30, 2025 December 31, 2024 Cash and cash equivalents 8,786 3,182 Trade receivables 7,626 7,102 Inventory 1,124 1,171 Short term other assets 1,761 1,598 Current assets 19,298 13,053 Tangible and intangible fixed assets 21,049 19,786 Right of use ass
Slide 17: Historical P&L Statements
Historical P&L Statements Reviewed Reviewed Change (%) Q2 2025 Q2 2024 Change (%) TLm H1 2025 H1 2024 Revenues 24,331 22,054 %10.3 11,871 10,400 %14.1 Cost of service (-) (17,851) (16,425) %8.7 (8,817) (7,809) %12.9 Gross profit 6,480 5,630 %15.1 3,053 2,591 %17.8 General administration expenses (-)
Slide 18: EBITDA Reconciliation
EBITDA Reconciliation Change Change TLm H1 2025 H1 2024 (%) Q2 2025 Q2 2024 (%) Revenue 24,331 22,054 10.3% 11,871 10,400 14.1% Cost of service (17,851) (16,425) 8.7% (8,817) (7,809) 12.9% Gross profit 6,480 5,630 15.1% 3,053 2,591 17.8% General administrative expenses (-) (2,173) (1,808) 20.2% (1,0